Vivos Therapeutics, Inc. (VVOS)
0.2765
-0.02
(-6.90%)
USD |
NASDAQ |
Aug 24, 16:00
0.2735
0.00 (0.00%)
After-Hours: 20:00
Vivos Therapeutics Debt to Equity Ratio : -3.278 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | -3.278 |
| March 31, 2026 | -10.78 |
| December 31, 2025 | -9.062 |
| September 30, 2025 | 4.936 |
| June 30, 2025 | 2.527 |
| March 31, 2025 | 0.3174 |
| December 31, 2024 | 0.1901 |
| September 30, 2024 | 0.2144 |
| June 30, 2024 | 0.2779 |
| March 31, 2024 | 3.234 |
| December 31, 2023 | 4.854 |
| September 30, 2023 | 45.74 |
| June 30, 2023 | 1.050 |
| Date | Value |
|---|---|
| March 31, 2023 | 0.331 |
| December 31, 2022 | 0.5026 |
| September 30, 2022 | 0.2889 |
| June 30, 2022 | 0.196 |
| March 31, 2022 | 0.1049 |
| December 31, 2021 | 0.0495 |
| September 30, 2021 | 0.039 |
| June 30, 2021 | 0.0347 |
| March 31, 2021 | 0.0882 |
| December 31, 2020 | 0.0763 |
| September 30, 2020 | -142.28 |
| March 31, 2020 | |
| December 31, 2019 | -2.281 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Hinge Health, Inc. | 0.0171 |
| Exlites Holdings International, Inc. | 0.00 |
| Xcelerate, Inc. | -0.8535 |
| Haemonetics Corp. | 1.403 |
| Pro-Dex, Inc. | 0.4463 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 24.14M |
| Total Liabilities (Quarterly) | 28.13M |
| Shareholders Equity (Quarterly) | -3.815M |
| Current Ratio | 0.2066 |
| Net Debt Paydown Yield | -33.63% |